Product Images Nifedipine

NIFEdipine is a medication that comes in extended-release tablets of 60mg each. These tablets should be swallowed whole and are not intended to be bitten or divided. The product insert contains the full prescribing information, precautions, and warnings. The tablets should be stored between 20° to 25° C (68°to 77° F) and protected from light and moisture. The Unit Dose package is not child-resistant and is intended for institutional use only. This medication is distributed by Ingenus Pharmaceuticals, LLC and Major Pharmaceuticals in the USA, and by Cardinal Health.*

This text presents the adverse effects percentages of Nifedipine extended-release tablets compared to placebo. The adverse effects reported include headache, fatigue, dizziness, constipation, and nausea. The table shows the percentage of patients who reported each of these side effects while taking the medication (Nifedipine) and while taking a placebo.*

This is a chart of adverse effects reported by patients taking Nifedipine Capsules compared to placebo. The chart shows the percentage of patients who reported each adverse effect out of a total of 226 patients taking Nifedipine Capsules and 235 patients taking placebo. The adverse effects reported include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*